New pill aims to keep endometrial cancer at bay after chemo
NCT ID NCT03555422
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This Phase 3 trial tested whether taking the drug selinexor as a maintenance pill after chemotherapy can help delay cancer progression in people with advanced or recurrent endometrial cancer. 263 participants who had responded to initial chemo were randomly assigned to receive either selinexor or a placebo. The study is now complete, and researchers are analyzing how long participants remained cancer-free.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- selinexor (a drug taken as a pill)
- What this could lead to
- If it works, this could offer a new maintenance option to delay cancer progression after initial chemotherapy for advanced or recurrent endometrial cancer.
- What could go wrong
- This is a completed Phase 3 trial, but results are not yet widely available. Selinexor may cause side effects like nausea, fatigue, or low blood counts, and it may not improve survival for all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ENDOMETRIAL CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
ALEXANDRA Hospital
Athens, Greece, 11528, Greece
-
AZ Turnhout
Turnhout, 2300, Belgium
-
Agostino Gemelli University Polyclinic Foundation
Rome, 30161, Italy
-
Arizona Oncology
Tucson, Arizona, 85711, United States
-
CHR Verviers
Verviers, 4800, Belgium
-
CHU UCL Namur, Site Sainte-Elisabeth
Namur, 5000, Belgium
-
Cartitas Klinikum Saarbrücken
Saarbrücken, 66113, Germany
-
Charite Berlin Universitatsmedizin
Berlin, 13353, Germany
-
Chongqing University Cancer Hospital
Chongqing, Shapingba District, 400000, China
-
Consorci Sanitari de Terrassa
Barcelona, 08227, Spain
-
DIAKOVERE KH gGmbH, Henriettenstift Hannover
Hanover, 30171, Germany
-
Euromedica General Clinic
Thessaloniki, Macedonia, 54645, Greece
-
Florida Cancer Specialists (Sarah Cannon Research Institute)
West Palm Beach, Florida, 33401, United States
-
General University Hospital in Prague
Prague, 12851, Czechia
-
Gynecological Cancer Institute of Chicago
Oak Lawn, Illinois, 60453, United States
-
HCA Midwest Health - Kansas City (Sarah Cannon Research Institute)
Kansas City, Missouri, 64132, United States
-
Hadassah Medical Center
Jerusalem, 9112001, Israel
-
Harbin Medical University Cancer Hospital
Harbin, Heilongjiang, 150040, China
-
Henan Cancer Hospital
Zhengzhou, Henan, China
-
Hillel Yaffe Medical Center
Hadera, 38100, Israel
-
Hospital Clínico Universitario Lozano Blesa
Zaragoza, 50009, Spain
-
Hospital Clínico Universitario de Valencia
Valencia, 46010, Spain
-
Hospital Na Bulovce
Prague, 18081, Czechia
-
Hospital Son Llàtzer
Palma, 071998, Spain
-
Hospital Universitari Clínic de Barcelona
Barcelona, 08036, Spain
-
Hospital Universitari Vall d' Hebrón
Barcelona, 08035, Spain
-
Hospital Universitario Donostia
San Sebastián, Gipuzkoa, 20014, Spain
-
Hospital Universitario Infanta Sofía
Madrid, 28702, Spain
-
Hospital Universitario Puerta de Hierro - Majadahonda
Madrid, 28220, Spain
-
Hospital Universitario Ramón y Cajal
Madrid, 28034, Spain
-
Hospital Universitario Virgen del Rocío
Seville, 41013, Spain
-
Hospital Universitario y Politécnico de La Fe
Valencia, 46026, Spain
-
Hunan Cancer Hospital
Changsha, Hunan, China
-
Iaso Hospital
Marousi, Athens, 151 23, Greece
-
Indiana University Simon Cancer Center
Indianapolis, Indiana, 46202, United States
-
Instituto Valenciano de Oncología
Valencia, 46009, Spain
-
Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale" - NAPOLI Struttura Complessa Oncologia Medica Uro-Ginecologica
Naples, 80131, Italy
-
Istituto Nazionale dei Tumori IRCCS - MILANO S.C. Ginecologia Oncologica
Milan, 20133, Italy
-
Istituto di Candiolo, FPO, IRCCS
Candiolo, 10060, Italy
-
Jan Yperman Ziekenhuis
Ieper, 8900, Belgium
-
Jiangxi Maternal and Child Health Hospital
Nanchang, Jiangxi, 330006, China
-
Klinikum der Universitat Munchen
Munich, 80337, Germany
-
Liaoning Cancer Hospital
Shenyang, Liaoning, 110042, China
-
London Health Sciences Centre (London Regional Cancer Centre)
London, Ontario, N6C 0A7, Canada
-
McGill University Health Centre (MUHC)
Montreal, Quebec, H4A 3J1, Canada
-
Memorial Sloan Kettering Cancer Center
New York, New York, 10065, United States
-
Moffitt Cancer Center
Tampa, Florida, 33612, United States
-
NYU Langone
New York, New York, 10016, United States
-
Oncology Associates of Oregon
Eugene, Oregon, 97401, United States
-
Parkview Research Center
Fort Wayne, Indiana, 46845, United States
-
Peking Union Medical College Hospital
Beijing, Beijing Municipality, 100730, China
-
Romagnolo Scientific Institute for the Study and Treatment of Tumors
Meldola, 47014, Italy
-
San Raffaele Hospital
Milan, 20132, Italy
-
Shaare Zedek Medical Center
Jerusalem, 9103102, Israel
-
Sheba Medical Center
Ramat Gan, 52621, Israel
-
Stanford University
Palo Alto, California, 94304, United States
-
Tennessee Oncology Nashville (Sarah Cannon Research Institute)
Nashville, Tennessee, 37203, United States
-
Texas Oncology DFW
Dallas, Texas, 75246, United States
-
Texas Oncology DFW
Fort Worth, Texas, 76104, United States
-
Texas Oncology, Austin
Austin, Texas, 78731, United States
-
UH Královské Vinohrady
Prague, 10034, Czechia
-
ULSS 3 SERENISSIMA UOC Oncologia Ed Ematologia Oncologica
Mirano, 30174, Italy
-
UZ Gent
Ghent, 9000, Belgium
-
Universitaire Ziekenhuizen K.U. Leuven
Leuven, 3000, Belgium
-
Universitatsklinikum Schleswig-Holstein
Kiel, 24105, Germany
-
University Health Network (PMCC)
Toronto, Ontario, M5G 2M9, Canada
-
University Hospital Brno
Brno, 60200, Czechia
-
University Hospital Dresden
Dresden, 01307, Germany
-
University Hospital Ostrava
Ostrava, 70852, Czechia
-
University of Oklahoma Health Sciences Center - Stephenson Cancer Center
Oklahoma City, Oklahoma, 73104, United States
-
University of Texas Southwestern Medical Center
Dallas, Texas, 75390, United States
-
Universitätsfrauenklinik Mainz
Mainz, 55131, Germany
-
Universitätsfrauenklinik Ulm
Ulm, 89070, Germany
-
VCU Massey Cancer Center
Richmond, Virginia, 23298, United States
-
Virgen de la Arrixaca University Clinical Hospital
Murcia, 30120, Spain
-
Wenzhou Medical University - The First Affiliated Hospital
Wenzhou, Zhejiang, 325000, China
-
Wolfson Medical Center
Holon, 58100, Israel
-
Women & Infants Hospital of Rhode Island
Providence, Rhode Island, 02905, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new drug combo revive Immunotherapy's power against resistant tumors?
- What raises endometrial cancer risk in black women? a study digs in
- Can immunotherapy plus hormones spare the womb in early endometrial cancer?
- Can a new drug tackle Hard-to-Treat gynecologic cancers?
- Can a pill restore the Body's tumor suppressor to fight multiple cancers?
- Could gentle yoga and breathing ease Cancer's lingering toll?